| 1. |
Bhardwaj A, Yadav A, Yadav M, et al. Genetic dissection of non-syndromic retinitis pigmentosa[J]. Indian J Ophthalmol, 2022, 70(7): 2355-2385. DOI: 10.4103/ijo.IJO_46_22.
|
| 2. |
Petrs-Silva H, Linden R. Advances in gene therapy technologies to treat retinitis pigmentosa[J]. Clin Ophthalmol, 2014, 8: 127-136. DOI: 10.2147/OPTH.S38041.
|
| 3. |
Yang YJ, Peng J, Ying D, et al. A brief review on the pathological role of decreased blood flow affected in retinitis pigmentosa[J/OL]. J Ophthalmol, 2018, 2018: 3249064[2018-02-25]. https://pubmed.ncbi.nlm.nih.gov/29682340/. DOI: 10.1155/2018/3249064.
|
| 4. |
Newton F, Megaw R. Mechanisms of photoreceptor death in retinitis pigmentosa[J/OL]. Genes (Basel), 2020, 11(10): 1120[2020-09-24]. https://pubmed.ncbi.nlm.nih.gov/32987769/. DOI: 10.3390/genes11101120.
|
| 5. |
Mansouri V. X-linked retinitis pigmentosa gene therapy: preclinical aspects[J]. Ophthalmol Ther, 2023, 12(1): 7-34. DOI: 10.1007/s40123-022-00602-y.
|
| 6. |
姜海鷗, 王義旺, 金慶麗. X連鎖隱性遺傳視網膜色素變性一家系RPGR和RP2基因的突變分析[J]. 廣東醫學, 2015, 36(10): 1537-1539. DOI: 10.13820/j.cnki.gdyx.2015.10.016.Jiang HO, Wang YW, Jin QL. Analysis of mutations in RPGR and RP2 genes in a family with X-linked recessive retinitis pigmentosa[J]. Guangdong Medical Journal, 2015, 36(10): 1537-1539. DOI: 10.13820/j.cnki.gdyx.2015.10.016.
|
| 7. |
Shu X, Black GC, Rice JM, et al. RPGR mutation analysis and disease: an update[J]. Hum Mutat, 2007, 28(4): 322-328. DOI: 10.1002/humu.20461.
|
| 8. |
Sharon D, Bruns GA, McGee TL, et al. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function[J]. Invest Ophthalmol Vis Sci, 2000, 41(9): 2712-2721.
|
| 9. |
Kühnel K, Veltel S, Schlichting I, et al. Crystal structure of the human retinitis pigmentosa 2 protein and its interaction with Arl3[J]. Structure, 2006, 14(2): 367-378. DOI: 10.1016/j.str.2005.11.008.
|
| 10. |
Bartolini F, Bhamidipati A, Thomas S, et al. Functional overlap between retinitis pigmentosa 2 protein and the tubulin-specific chaperone cofactor C[J]. J Biol Chem, 2002, 277(17): 14629-14634. DOI: 10.1074/jbc.M200128200.
|
| 11. |
Breuer DK, Yashar BM, Filippova E, et al. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa[J]. Am J Hum Genet, 2002, 70(6): 1545-1554. DOI: 10.1086/340848.
|
| 12. |
Rosenberg T, Schwahn U, Feil S, et al. Genotype-phenotype correlation in X-linked retinitis pigmentosa 2 (RP2)[J]. Ophthalmic Genet, 1999, 20(3): 161-172. DOI: 10.1076/opge.20.3.161.2278.
|
| 13. |
李楊, 董冰, 胡愛蓮, 等. 一個X-連鎖視網膜色素變性中國家系的RPGR基因的新突變[J]. 中華醫學遺傳學雜志, 2005, 22(4): 396-398. DOI: 10.3760/j.issn:1003-9406.2005.04.010.Li Y, Dong B, Hu AL, et al. A novel RPGR gene mutation in a Chinese family with X-linked dominant retinitis pigmentosa[J]. Chin J Med Genet, 2005, 22(4): 396-398. DOI: 10.3760/j.issn:1003-9406.2005.04.010.
|
| 14. |
Churchill JD, Bowne SJ, Sullivan LS, et al. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa[J]. Invest Ophthalmol Vis Sci, 2013, 54(2): 1411-1416. DOI: 10.1167/iovs.12-11541.
|
| 15. |
Kaplan J, Pelet A, Martin C, et al. Phenotype-genotype correlations in X linked retinitis pigmentosa[J]. J Med Genet, 1992, 29(9): 615-623. DOI: 10.1136/jmg.29.9.615.
|
| 16. |
Kurata K, Hosono K, Hayashi T, et al. X-linked retinitis pigmentosa in Japan: clinical and genetic findings in male patients and female carriers[J/OL]. Int J Mol Sci, 2019, 20(6): 1518[2019-03-26]. https://pubmed.ncbi.nlm.nih.gov/30917587/. DOI: 10.3390/ijms20061518.
|
| 17. |
施曉萌, 張宇, 劉艷, 等. 近20年色素性視網膜炎基因治療現狀的文獻計量學分析[J]. 中華眼底病雜志, 2025, 41(3): 221-230. DOI: 10.3760/cma.j.cn511434-20240929-00367.Shi XM, Zhang Y, Liu Y, et al. Bibliometric analysis of gene therapy for retinitis pigmentosa in recent 20 years[J]. Chin J Ocul Fundus Dis, 2025, 41(3): 221-230. DOI: 10.3760/cma.j.cn511434-20240929-00367.
|
| 18. |
佘凱芩, 陳沁, 陸方. 基于CRISPR/Cas9的基因編輯技術在遺傳性視網膜疾病治療中的研究進展[J]. 中華眼底病雜志, 2023, 39(7): 605-610. DOI: 10.3760/cma.j.cn511434-20220908-00493.She KQ, Chen Q, Lu F, et al. The progress of the gene editing therapy of inherited retinal diseases based on CRISPR/Cas9[J]. Chin J Ocul Fundus Dis, 2023, 39(7): 605-610. DOI: 10.3760/cma.j.cn511434-20220908-00493.
|
| 19. |
Su J, She K, Song L, et al. In vivo base editing rescues photoreceptors in a mouse model of retinitis pigmentosa[J]. Mol Ther Nucleic Acids, 2023, 31: 596-609. DOI: 10.1016/j.omtn.2023.02.011.
|